These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35678446)

  • 1. [Analysis on the Characteristics of Quality Variation of National Medical Device Supervision and Inspection in 2020].
    Li X; Zhang XT; Hao Q; Zhu J; Ma JZ; Yang GJ
    Zhongguo Yi Liao Qi Xie Za Zhi; 2022 May; 46(3):326-331. PubMed ID: 35678446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis on the Quality Status of in Vitro Diagnostic Reagents for National Medical Device Supervision and Inspection in 2020].
    Li X; Zhang X; Hao Q; Zhu J; Hong W
    Zhongguo Yi Liao Qi Xie Za Zhi; 2022 Jul; 46(4):459-463. PubMed ID: 35929166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of Quality Status of National Medical Device Supervision and Inspection in 2019].
    Li X; Zhang X; Hao Q; Zhu J; Ma J
    Zhongguo Yi Liao Qi Xie Za Zhi; 2021 Feb; 45(1):85-89. PubMed ID: 33522184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of Quality Status of National Medical Device Supervision and Inspection from 2013 to 2016].
    Zhang X; Hao Q; Shi X; Zhu J; Luo Q; Zhang Q; Cheng S
    Zhongguo Yi Liao Qi Xie Za Zhi; 2017 May; 41(3):216-219. PubMed ID: 29862772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Risk Point Analysis of Product Quality and Safety in Sample Inspection of National Medical Device Supervision].
    Hao Q; Zhang X; Zhu J; Shi X; Li X; Zhu N
    Zhongguo Yi Liao Qi Xie Za Zhi; 2019 May; 43(3):209-213. PubMed ID: 31184081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis and Suggestions on Status Quo of Commissioned Production under Medical Device Marketing Authorization Holder System in China].
    Xing B; He T; Zhang D; Liang Y
    Zhongguo Yi Liao Qi Xie Za Zhi; 2022 Mar; 46(2):195-199. PubMed ID: 35411750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Discussion on Supervision and Sampling of Biochemical Test Kits].
    Huang Y; Wu J
    Zhongguo Yi Liao Qi Xie Za Zhi; 2022 Mar; 46(2):216-218. PubMed ID: 35411754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of Variety Selection for Medical Device Supervision and Inspection].
    Shi X; Zhang X; Zhu J; Hao Q; Li X
    Zhongguo Yi Liao Qi Xie Za Zhi; 2019 May; 43(3):202-204. PubMed ID: 31184079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The current situation and suggestions on the institutes for medical devices test in China].
    Yang X; Li X; Mu R; Wang C; Li J
    Zhongguo Yi Liao Qi Xie Za Zhi; 2014 Jan; 38(1):57-60. PubMed ID: 24839853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Consideration and Practice of Introducing Third-party Certification Institutions to Participate in Post-marketing Supervision of Medical Devices].
    Lin S; Li Y; Mu Y
    Zhongguo Yi Liao Qi Xie Za Zhi; 2019 Nov; 43(6):442-446. PubMed ID: 31854533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sampling Procedures for Inspection by Attributes and Application on Field of Medical Devices].
    Zhang B; Wan M; Zhang X; Xiong W; Li W; Chen C
    Zhongguo Yi Liao Qi Xie Za Zhi; 2022 Sep; 46(5):538-544. PubMed ID: 36254483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis and Prospect of Classifcation Management of Medical Device for Rehabilitation].
    Zhang C; Wang Y; Sun H; Mu R; Yu X; Li J
    Zhongguo Yi Liao Qi Xie Za Zhi; 2017 Sep; 41(5):365-368. PubMed ID: 29862727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances in Medical Device Standard System].
    Xu H; Wang Y; Yang X; Li J
    Zhongguo Yi Liao Qi Xie Za Zhi; 2018 Jan; 42(1):49-52. PubMed ID: 29862747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Research and Application of Quality Inspection Information System in Medical Device Manufacturers].
    Lin D; Guo Y; Zhu Q
    Zhongguo Yi Liao Qi Xie Za Zhi; 2021 Feb; 45(1):17-21. PubMed ID: 33522170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Discussion of Enlightenment from the Reorganization of CDRH Regulatory for Medical Device].
    Shang H; Zhang S
    Zhongguo Yi Liao Qi Xie Za Zhi; 2020 Feb; 44(2):154-157. PubMed ID: 32400990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A Brief Discussion on the in Vitro Diagnostic Reagent Inspection Practice of
    He T; Chu S; Xie J
    Zhongguo Yi Liao Qi Xie Za Zhi; 2023 May; 47(3):324-327. PubMed ID: 37288638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of Risk in Production of MRI and Some Suggestions for Field Inspection].
    Liu Y; Yang Y
    Zhongguo Yi Liao Qi Xie Za Zhi; 2021 Sep; 45(5):542-545. PubMed ID: 34628769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research on supervision strategy of physical examination institutions after abolishing administrative approval].
    Zhang WW; Li Y; Xiao H
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2018 Dec; 36(12):941-942. PubMed ID: 30812088
    [No Abstract]   [Full Text] [Related]  

  • 19. [Software as medical devices/medical apps : Tasks, requirements, and experiences from the point of view of a competent authority].
    Terhechte A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Mar; 61(3):321-327. PubMed ID: 29318338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Discussion about Supervision Model of Customized Medical Device].
    Sun J; Wu J; Qian H; Liu B; Zhang S
    Zhongguo Yi Liao Qi Xie Za Zhi; 2017 Nov; 41(6):432-435. PubMed ID: 29862704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.